• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal | Fierce Biotech


<